European and US regulators approve AbbVie's new combo for all hepatitis C genotypes
Demand for access to NHS PrEP trial looks set to outstrip places
PrEP demand in England is rapidly accelerating – and most will want to join the trial
What marks out HIV controllers from others?
Why curing HIV may be like curing cancer – and may be as difficult
Can we achieve a complete HIV cure in more patients?
VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment
Long-acting NRTI shows promise for HIV treatment and PrEP
Stillbirth more frequent in women with HIV in UK and Ireland than in general population
